Cytogenetic analysis of 54 cases of myelodysplastic syndromeJOTTERAND-BELLOMO, M; PARLIER, V; SCHMIDT, P. M et al.Cancer genetics and cytogenetics. 1990, Vol 46, Num 2, pp 157-172, issn 0165-4608, 16 p.Article

Syndromes myélodysplasiquesFENAUX, Pierre.Hématologie (Montrouge). 2007, Vol 13, pp 45-49, issn 1264-7527, 5 p., NS1Conference Paper

Les syndromes myélodysplasiques ou états préleucémiques = Myelodysplastic syndromeGARDIN, Claude; FENAUX, Pierre.Concours médical (Paris). 2004, Vol 126, Num 27, pp 1577-1581, issn 0010-5309, 5 p.Article

Les syndromes myélodysplasiques (1ère partie) = Myelodysplastic syndromes (1st part)FENAUX, P.Pathologie et biologie. 1997, Vol 45, Num 7, issn 0369-8114, 79 p.Serial Issue

Les syndromes myélodysplasiquesFENAUX, Pierre.Hématologie (Montrouge). 2006, Vol 12, pp 39-42, issn 1264-7527, 4 p., NS2Conference Paper

Syndromes myélodysplasiquesFENAUX, Pierre.Hématologie (Montrouge). 2005, Vol 11, pp 43-45, issn 1264-7527, 3 p., NS4Conference Paper

Fifth international symposium on myelodysplastic syndromes, Prague, Czech Republic, 21-24 April 1999NEUWIRTOVA, Radana; CMUNT, Eduard; JELINEK, Jaroslav et al.Leukemia research. 1999, Vol 23, issn 0145-2126, 92 p., SUP1Conference Proceedings

Biology and pathogenesis of the myelodysplastic syndromesLIST, A. F; JACOBS, A.Seminars in oncology. 1992, Vol 19, Num 1, pp 14-24, issn 0093-7754Article

Les syndromes myélodysplasiquesFENAUX, Pierre; GARDIN, Claude.Hématologie (Montrouge). 2004, Vol 10, pp 36-40, issn 1264-7527, 5 p., NS1Conference Paper

Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS)LIST, Alan F.Seminars in oncology. 2005, Vol 32, Num 4, pp S31-S35, issn 0093-7754, SUP5Article

6th International Symposium on Myelodysplastic Syndromes, 14-17 June 2001, Stockholm, SwedenLeukemia research. 2001, Vol 25, issn 0145-2126, 89 p., SUP1Conference Proceedings

The myelodysplastic syndromes : towards a functional classificationMIJOVIC, A; MUFTI, G. J.Blood reviews. 1998, Vol 12, Num 2, pp 73-83, issn 0268-960XArticle

Myelodysplastic syndromes in the elderlyMANSOURI, A; LIPSCHITZ, D. A.Journal of the American Geriatrics Society. 1992, Vol 40, Num 4, pp 386-391, issn 0002-8614Article

Therapeutic strategies and supportive care in myelodysplastic syndromesBENNETT, John M.Leukemia research. 1998, Vol 22, issn 0145-2126, 49 p., SUP1Conference Proceedings

Dysmyélopoïèse = DysmyelopoeisisGARDIN, Claude; FENAUX, Pierre.La Revue du praticien (Paris). 2005, Vol 55, Num 17, pp 1957-1961, issn 0035-2640, 5 p.Article

Update on myelodysplastic syndromes: New approaches to classification and therapyLANGSTON, Amelia A; WALLING, Radhika; WINTON, Elliott F et al.Seminars in oncology. 2004, Vol 31, Num 2, pp 72-79, issn 0093-7754, 8 p., SUP4Conference Paper

Kit ligand improves in vitro erythropoiesis in myelodysplastic syndromeBACKX, B; BROEDERS, L; LÖWENBERG, B et al.Blood. 1992, Vol 80, Num 5, pp 1213-1217, issn 0006-4971Article

Syndromes myélodysplasiques (SMD) = Myelodysplastic syndromeFENAUX, Pierre.Hématologie (Montrouge). 2003, Vol 9, Num 2, pp 29-32, issn 1264-7527, 4 p., NSArticle

Thymopentin in the treatment of myelodysplastic syndromesLATAGLIATA, R; PETTI, M. C; ALOE SPIRITI, M. A et al.Acta haematologica. 1991, Vol 86, Num 2, issn 0001-5792, p. 115Article

Genetic abnormalities in myelodysplastic syndromeJACOBS, A.Cancer genetics and cytogenetics. 1991, Vol 56, Num 1, pp 1-6, issn 0165-4608Conference Paper

Alternative treatments for myelodysplastic syndromesSEKERES, Mikkael; LIST, Alan.Seminars in hematology. 2005, Vol 42, Num 3, pp S32-S37, issn 0037-1963, SUP2Article

Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplatic syndromesKELSEY, S. M; NEWLAND, A. C; CUNNINGHAM, J et al.Lancet (British edition). 1992, Vol 340, Num 8814, pp 316-317, issn 0140-6736Article

The myelodysplastic syndromesOSCIER, D. G.BMJ. British medical journal (International ed.). 1997, Vol 314, Num 7084, pp 883-886, issn 0959-8146Article

Anémies réfractaires: la place des facteurs de croissance hématopoïétique = Refractory anemies: the place of hematopoietic growth factorPATRI, B; HERMINE, O.Concours médical (Paris). 1995, Vol 117, Num 11, pp 820-823, issn 0010-5309Article

The 5q syndrome : a single-institution study of 43 consecutive patientsMATHEW, P; TEFFERI, A; DEWALD, G. W et al.Blood. 1993, Vol 81, Num 4, pp 1040-1045, issn 0006-4971Article